echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > There are 120 million patients with chronic kidney disease in China About 40% of diabetic patients have chronic kidney disease

    There are 120 million patients with chronic kidney disease in China About 40% of diabetic patients have chronic kidney disease

    • Last Update: 2022-09-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The latest statistics show that there are about 463 million people with diabetes worldwide, which is expected to increase to 700 million


    There are 120 million people with chronic kidney disease in China

    Approximately 40% of people with diabetes mellitus have chronic kidney disease

    According to statistics, there are currently up to 120 million patients


    It is reported that the factors affecting the progression of chronic kidney disease include unchangeable factors, such as age, sex, ethnicity, family history and duration of diabetes, as well as modifiable factors, such as blood glucose, blood pressure, proteinuria, blood lipids and lifestyle


    Currently, about 40% of people with diabetes have chronic kidney disease


    However, the diagnosis rate of chronic kidney disease is low, with up to 90% of patients not knowing they have the disease


    Patients with chronic kidney disease should not only control blood sugar, but also reduce cardiovascular adverse events

    Antihypertensive, hypoglycemic and other joint protection of the kidneys

    Damage to individual organs can lead to dysfunction of other organs, which is also the leading cause


    In addition, the guidelines also point out that patients with type 2 diabetes with confirmed diabetes mellitus, regardless of whether the blood glucose is up to standard, if the eGFR ≥ 45 ml · min · (1.


    Recently, the first sodium-glucose synergistic transporter-2 inhibitor dapagliflozin in China has been approved for marketing



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.